Schroeder, C., Navid-Hill, E., Meiners, J., Hube-Magg, C., Kluth, M., Makrypidi-Fraune, G., . . . Höflmayer, D. (2019). Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget.
Παραπομπή Chicago StyleSchroeder, Cornelia, et al. "Nuclear ELAC2 Overexpression Is Associated With Increased Hazard for Relapse After Radical Prostatectomy." Oncotarget 2019.
Παραπομπή MLASchroeder, Cornelia, et al. "Nuclear ELAC2 Overexpression Is Associated With Increased Hazard for Relapse After Radical Prostatectomy." Oncotarget 2019.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.